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INTRODUCTION
Trichotillomania is considered a behavioral disorder and is 
characterized	by	the	recurring	habit	of	pulling	one’s	hair,	resulting	




It can occur at any age but is more prevalent in adolescents and fe-
males	(88%	to	94%).	 Its	occurrence	in	childhood	is	not	uncommon	




zoar,	 resulting	 in	 serious	 gastrointestinal	 complications.1 Several 
treatments	 have	 been	proposed,	 including	psychotherapy	 and	 the	




glutamate modulating agent that appears to offer a promising treat-
ment	option.	 It	 acts	 by	 reducing	oxidative	 stress	 and	normalizing	
glutaminergic transmission.6	In	this	study,	we	report	a	case	of	tricho-
tillomania with an excellent response to N-acetylcysteine.5,6
CASE REPORT
The	patient	was	an	11-year-old	male	student,	born	and	liv-
ing	 in	 the	 state	 of	 São	Paulo	 (SP).	He	 reported	 the	 occurrence	 of	
thinning hair on the scalp over the previous six months. The mother 
said that the child had a habit of pulling out his hair. The patient 
was in irregular counseling and had developed a relationship prob-
lem with his father. He had a personal history of asthma and atop-
ic	dermatitis.	A	dermatological	examination	revealed	an	extensive	
area of alopecia in the frontal region. Gentle traction was negative 
An Bras Dermatol. 2017;92(4):537-9.
(Figures	1	and	2).	Dermoscopy	revealed	the	presence	of	broken	hairs	
of	different	sizes,	multiple	black	spots	and	a	V-sign	(Figure	3).	Treat-
ment with N-acetylcysteine was therefore initiated  (1200 mg/day 
for	three	months).	The	patient’s	outlook	improved	dramatically,	but	










FIgure 2: Presence of thinning hair with hairs of different lengths
FIgure 3: Dermoscopy	showing	broken	hairs	of	different	lengths,	
black	spots	and	a	V-sign
FIgure 4: Improvement after six months of treatment
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cal differences and different clinical response to drugs used suggest 
pathophysiological differences. Trichotillomania has a negative im-
pact	on	the	patient’s	quality	of	life,	interfering	with	social,	personal	
and occupational life.4,6 The diagnosis of trichotillomania remains 
challenging	and	 is	established	on	a	clinical,	dermoscopic	and	his-
topathological basis. Dermoscopy is a noninvasive method that ap-
pears to be a very useful tool that increases diagnostic accuracy and 





crohemorrhage. The main differential diagnosis is alopecia areata. 
Some	 dermoscopic	 signs	 are	 common	 to	 both	 entities.	 The	 black	
spots observed in trichotillomania exhibit variability in diameter 
and	shape,	distinguishing	them	from	alopecia	areata,	in	which	these	






ment	 options,	 such	 as	 glutamate	 modulating	 agents.4,6 Evidence 
suggests the presence of abnormalities in glutamate metabolism in 
patients with OCDs. High levels of glutamate are associated with 
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the ability of glutamate modulating agents to regulate impulse con-
trol	is	remarkable,	which	makes	these	drugs	of	great	interest	for	the	
treatment of trichotillomania. N-acetylcysteine is a glutamate mod-
ulating agent that appears to offer a promising treatment option. It 
has	neurochemical,	antioxidant,	mucolytic,	anti-inflammatory	and	





endogenous antioxidant. Cysteine is thought to cross the blood-
brain barrier via sodium-dependent transporters and is then con-
verted to cystine. High levels of cystine  stimulate glutamate-cystine 
exchange	 via	 the	 glutamate-cystine	 transporter,	 which	 increases	
non-synaptic glutamate levels. This process activates glutamate re-
ceptors	(mGluR2/3)	in	the	presynaptic	neurons	responsible	for	the	
inhibition of synaptic glutamate release and restores extracellular 
levels	 of	 this	 substance.	 In	 the	 intracellular	 environment,	 cystine	
is	 then	 converted	 to	 cysteine,	which	 is	 used	 to	 produce	 glutathi-
one. The regulation of this transporter system has been shown to 
improve	impulse	control	and	play	a	key	role	 in	OCDRDs	such	as	
trichotillomania.4,6		q
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